BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36103746)

  • 21. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
    Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X
    Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
    Dua R; Bhardwaj T; Ahmad I; Somvanshi P
    PLoS One; 2024; 19(4):e0287864. PubMed ID: 38626166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
    Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
    BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
    Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
    Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
    Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of
    Zang Y; Zhao R; Wang T; Gao Y; Chen L; Liu S; Wang Y; Xue F
    Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37114556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-expression network analysis identified atypical chemokine receptor 1 (ACKR1) association with lymph node metastasis and prognosis in cervical cancer.
    Liu J; Li S; Lin L; Jiang Y; Wan Y; Zhou S; Cheng W
    Cancer Biomark; 2020; 27(2):213-223. PubMed ID: 32083574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development.
    Luo Y; Wu Y; Peng Y; Liu X; Bie J; Li S
    Ir J Med Sci; 2016 Feb; 185(1):231-9. PubMed ID: 25786624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
    Zhang H; Huo J; Jiang W; Shan Q
    Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics Analysis of Key Genes and Pathways of Cervical Cancer.
    Chen H; Wang X; Jia H; Tao Y; Zhou H; Wang M; Wang X; Fang X
    Onco Targets Ther; 2020; 13():13275-13283. PubMed ID: 33402836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 36. Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes.
    Lin R; Wang Y; Ji K; Liu Z; Xiao S; Zhou D; Chen Q; Shi B
    Mol Med Rep; 2018 Mar; 17(3):4351-4359. PubMed ID: 29328449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
    Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
    Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
    Shi H; Xu H; Chai C; Qin Z; Zhou W
    J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.